LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Maheswaran, Hendramoorthy; Petrou, Stavros; MacPherson, Peter; Choko, Augustine T.; Kumwenda, Felistas; Lalloo, David G.; Clarke, Aileen; Corbett, Elizabeth L. (2016)
Publisher: BioMed Central Ltd.
Languages: English
Types: Article
Subjects: RC
Background:\ud HIV self-testing (HIVST) has been found to be highly effective, but no cost analysis has been undertaken to guide the design of affordable and scalable implementation strategies.\ud \ud Methods:\ud Consecutive HIV self-testers and facility-based testers were recruited from participants in a community cluster-randomised trial (ISRCTN02004005) investigating the impact of offering HIVST in addition to facility-based HIV testing and counselling (HTC). Primary costing studies were undertaken of the HIVST service and of health facilities providing HTC to the trial population. Costs were adjusted to 2014 US$ and INT$. Recruited participants were asked about direct non-medical and indirect costs associated with accessing either modality of HIV testing, and additionally their health-related quality of life was measured using the EuroQol EQ-5D.\ud \ud Results:\ud A total of 1,241 participants underwent either HIVST (n = 775) or facility-based HTC (n = 446). The mean societal cost per participant tested through HIVST (US$9.23; 95 % CI: US$9.14-US$9.32) was lower than through facility-based HTC (US$11.84; 95 % CI: US$10.81-12.86). Although the mean health provider cost per participant tested through HIVST (US$8.78) was comparable to facility-based HTC (range: US$7.53-US$10.57), the associated mean direct non-medical and indirect cost was lower (US$2.93; 95 % CI: US$1.90-US$3.96). The mean health provider cost per HIV positive participant identified through HIVST was higher (US$97.50) than for health facilities (range: US$25.18-US$76.14), as was the mean cost per HIV positive individual assessed for anti-retroviral treatment (ART) eligibility and the mean cost per HIV positive individual initiated onto ART. In comparison to the facility-testing group, the adjusted mean EQ-5D utility score was 0.046 (95 % CI: 0.022-0.070) higher in the HIVST group.\ud \ud Conclusions:\ud HIVST reduces the economic burden on clients, but is a costlier strategy for the health provider aiming to identify HIV positive individuals for treatment. The provider cost of HIVST could be substantially lower under less restrictive distribution models, or if costs of oral fluid HIV test kits become comparable to finger-prick kits used in health facilities.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
    • 2. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657-66.
    • 3. UNAIDS. The Gap Report. 2014. Available at: http://www.unaids.org/en/ resources/campaigns/2014gapreport. (Accessed May 2015).
    • 4. Staveteig S, Wang S, Head S, Bradley S, Nybro E. Demographic patterns of HIV testing uptake in sub-Saharan Africa. DHS Comparative Reports No. 30, In., vol. 15. Calverton: ICF International; 2013.
    • 5. UNAIDS. DIAGNOSTICS ACCESS INITIATIVE to achieve the 90-90-90 treatment target. 2014. http://www.unaids.org/sites/default/files/media_asset/ 20150422_diagnostics_access_initiative.pdf. (Accessed May 2015).
    • 6. Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, et al. Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. J Acquir Immune Defic Syndr. 2006;41(2):218-24.
    • 7. MacPherson P, Corbett EL, Makombe SD, van Oosterhout JJ, Manda E, Choko AT, et al. Determinants and consequences of failure of linkage to antiretroviral therapy at primary care level in Blantyre, Malawi: a prospective cohort study. PLoS One. 2012;7(9):e44794.
    • 8. Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What is the impact of home-based HIV counseling and testing on the clinical status of newly enrolled adults in a large HIV care program in western Kenya? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012; 54(2):275-281.
    • 9. Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, et al. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med. 2009;6(12):e1000189.
    • 10. Beyrer C, Birx DL, Bekker LG, Barre-Sinoussi F, Cahn P, Dybul MR, et al. The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will. Lancet. 2015;386(9993):505-7.
    • 11. Suthar AB, Ford N, Bachanas PJ, Wong VJ, Rajan JS, Saltzman AK, et al. Towards universal voluntary HIV testing and counselling: a systematic review and metaanalysis of community-based approaches. PLoS Med. 2013;10(8):e1001496.
    • 12. Sharma M, Ying R, Tarr G, Barnabas R. Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa. Nature. 2015;528(7580):S77-85.
    • 13. Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8(10):e1001102.
    • 14. MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, et al. Effect of optional home initiation of HIV care following HIV selftesting on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial. JAMA. 2014;312(4):372-9.
    • 15. Choko AT, MacPherson P, Webb EL, Willey BA, Feasy H, Sambakunsi R, et al. Uptake, accuracy, safety, and linkage into care over two years of promoting annual self-testing for HIV in Blantyre, Malawi: a community-based prospective study. PLoS Med. 2015;12(9):e1001873.
    • 16. Corbett EL. Intensified HIV/TB prevention linking home-based HIV testing, including the option of self-testing, with HIV care: a cluster-randomised trial in Blantyre, Malawi. http://www.controlled-trials.com/ISRCTN02004005/ ISRCTN02004005.
    • 17. MacPherson P, Choko AT, Webb EL, Thindwa D, Squire SB, Sambakunsi R, et al. Development and validation of a global positioning system-based “Map Book” system for categorizing cluster residency status of community members living in high-density urban slums in Blantyre, Malawi. Am J Epidemiol. 2013;177(10):1143-7.
    • 18. UNAIDS. Manual for costing HIV facilities and services. 2011. Available at: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/ documents/document/2011/20110523_manual_costing_HIV_facilities_en. pdf. (Accessed May 2014).
    • 19. Drummond MF, Sculpher MJ, Torrance GW. Methods for the economic evaluation of health care programmes. New York, USA: Oxford University Press; 2005.
    • 20. Pritchard C, Sculpher M. Productivity costs: principles and practice in economic evaluation: Office of Health Economics, London; 2000. Available at:https://www.ohe.org/publications/productivity-costs-principles-andpractice-economic-evaluation. (Accessed May 2015).
    • 21. Evans DB, Edejer TT, Adam T, Lim SS. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ. 2005;331(7525):1137-40.
    • 22. Idler EL, Benyamini Y. Self-rated health and mortality: a review of twentyseven community studies. J Health Soc Behav. 1997;38(1):21-37.
    • 23. Macpherson P, Lalloo DG, Thindwa D, Webb EL, Squire SB, Chipungu GA, et al. A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting. J Acquir Immune Defic Syndr. 2014;65(2):e74-8.
    • 24. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11): 1095-108.
    • 25. EuroQol. EQ-5D-3L User guide. http://www.euroqol.org/fileadmin/user_ upload/Documenten/PDF/Folders_Flyers/EQ-5D-3L_UserGuide_2015.pdf. (Accessed September 2013).
    • 26. EuroQol G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.
    • 27. Jelsma J, Hansen K, De Weerdt W, De Cock P, Kind P. How do Zimbabweans value health states? Popul Health Metr. 2003;1(1):11.
    • 28. Filmer D, Pritchett LH. Estimating wealth effects without expenditure dataor tears: an application to educational enrollments in states of India. Demography. 2001;38(1):115-32.
    • 29. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320(7243):1197-200.
    • 30. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9(4):197-204.
    • 31. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461-94.
    • 32. Powell JL. Least absolute deviations estimation for the censored regression model. J Econ. 1984;25(3):303-25.
    • 33. Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9(8):901-10.
    • 34. Papke LE, Wooldridge JM. Econometric methods for fractional response variables with an application to 401 (K) plan participation rates. J Appl Econ. 1996;11(6):619-32.
    • 35. Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care. 2007;19(5):626-36.
    • 36. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ. 1996;5(2):141-54.
    • 37. WHO. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. http://whqlibdoc.who.int/ publications/2011/9789241502986_eng.pdf?ua=1. (Accessed May 2014).
    • 38. Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda. Health Policy Plan. 2005;20(2):109-16.
    • 39. Wringe A, Roura M, Urassa M, Busza J, Athanas V, Zaba B. Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS Care. 2009;21(5):632-7.
    • 40. World Bank. Poverty. http://povertydata.worldbank.org/poverty/country/ MWI. (Accessed March 2015).
    • 41. Scott PA. Unsupervised self-testing as part public health screening for HIV in resource-poor environments: some ethical considerations. AIDS Behav. 2014;18 Suppl 4:S438-44.
    • 42. Hensen B, Baggaley R, Wong VJ, Grabbe KL, Shaffer N, Lo YR, et al. Universal voluntary HIV testing in antenatal care settings: a review of the contribution of provider-initiated testing & counselling. Trop Med Int Health. 2012;17(1):59-70.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Funded by projects

  • WT | Community-wide TB case-findi...
  • WT | The cost-effectiveness of ho...
  • WT | Wellcome Trust Clinical PhD ...

Cite this article